Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.44 |
| ▸ | TNIK | Q9UKE5 | 7/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11550210 | 0.94 | TNIK (0.45) | HTTASIC3TNIKLMNAL3MBTL1 | |
| SCHEMBL11552961 | 0.89 | HAO1 (0.49) | HTTASIC3TNIKLMNAL3MBTL1 | |
| SCHEMBL12391039 | 0.89 | ASIC3 (0.50) | HTTASIC3LMNAL3MBTL1MAPT | |
| SCHEMBL13597759 | 0.82 | HRH3 (0.41) | HAO1FFAR1APPGRM5 | |
| SCHEMBL12711667 | 0.80 | APP (0.47) | HTTASIC3LMNAL3MBTL1MAPT | |
| SCHEMBL14268091 | 0.80 | ASIC3 (0.49) | HTTASIC3LMNAL3MBTL1MAPT | |
| SCHEMBL1571249 | 0.78 | ASIC3 (0.44) | HTTASIC3LMNAL3MBTL1MAPT | |
| SCHEMBL18561130 | 0.78 | MAPT (0.53) | HTTASIC3LMNAL3MBTL1MAPT | |
| SCHEMBL6865029 | 0.78 | KIF11 (0.45) | HTTASIC3LMNAL3MBTL1MAPT | |
| SCHEMBL3448180 | 0.78 | APP (0.54) | HTTASIC3LMNAL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1688424-B1 | PHOSPHONIUM BORATE COMPOUND AND METHOD OF USING THE SAME | HOKKO CHEM IND CO (JP) | 2016-01-13 | — | — | EP | disclosed |
| US-8604249-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-12-10 | — | — | US | disclosed |
| US-8124809-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| US-7728176-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20070098616-A1 | Process for producing phosponium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1688424-A1 | PROCESS FOR PRODUCING PHOSPHONIUM BORATE COMPOUND, NOVEL PHOSPHONIUM BORATE COMPOUND, AND METHOD OF USING THE SAME | HOKKO CHEMICAL INDUSTRY CO. LTD. (JP) | 2006-08-09 | — | — | EP | disclosed |
| US-4412856-A | POSTERMERGENCE HERBICIDES | CIBA-GEIGY CORPORATION (US) | 1983-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | CA4, EPB41, MAPK4 | HTT 4744/4885ASIC3 219/4885TNIK 2882/4885 |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | EPB41, CA4, RBBP4 | HTT 4591/4885ASIC3 222/4885TNIK 2848/4885 |
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | PHOSPHO1, BRI3BP, CA4 | HTT 4628/4885ASIC3 214/4885TNIK 3272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.